UCL launches clinical trial to test if cough medicine ambroxol can slow down Parkinson's disease

UCL launches clinical trial to test if cough medicine ambroxol can slow down Parkinson's disease A major trial to test whether a cough medicine will slow down Parkinson’s has been announced.

Early studies suggest the drug, called ambroxol, appears to remove damaging proteins from the brain which are associated with the degenerative disease.

Currently there are no treatments capable of combating the neurological condition, which affects cells in the part of the brain that controls movement of the body. The Daily Mail

See also:

• Ambroxol for Parkinson’s: the story behind the medicine Cure Parkinson's
• Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease University College London Hospitals Biomedical Research Centre